Department of Microbiology & Immunology, Queen's University, Kingston, Ontario, Canada.
Cell Signal. 2010 Feb;22(2):314-24. doi: 10.1016/j.cellsig.2009.09.038. Epub 2009 Sep 29.
The ectodomain of TOLL-like receptors (TLR) is highly glycosylated with several N-linked gylcosylation sites located in the inner concave surface. The precise role of these sugar N-glycans in TLR receptor activation is unknown. Recently, we have shown that Neu1 sialidase and not Neu2, -3 and -4 forms a complex with TLR-2, -3 and -4 receptors on the cell-surface membrane of naïve and activated macrophage cells (Glycoconj J DOI 10.1007/s10719-009-9239-8). Activation of Neu1 is induced by TLR ligands binding to their respective receptors. Here, we show that endotoxin lipopolysaccharide (LPS)-induced MyD88/TLR4 complex formation and subsequent NFkappaB activation is dependent on the removal of alpha-2,3-sialyl residue linked to beta-galactoside of TLR4 by the Neu1 activity associated with LPS-stimulated live primary macrophage cells, macrophage and dendritic cell lines but not with primary Neu1-deficient macrophage cells. Exogenous alpha-2,3 sialyl specific neuraminidase (Streptoccocus pneumoniae) and wild-type T. cruzi trans-sialidase (TS) but not the catalytically inactive mutant TSAsp98-Glu mediate TLR4 dimerization to facilitate MyD88/TLR4 complex formation and NFkappaB activation similar to those responses seen with LPS. These same TLR ligand-induced NFkappaB responses are not observed in TLR deficient HEK293 cells, but are re-established in HEK293 cells stably transfected with TLR4/MD2, and are significantly inhibited by alpha-2,3-sialyl specific Maackia amurensis (MAL-2) lectin, alpha-2,3-sialyl specific galectin-1 and neuraminidase inhibitor Tamiflu but not by alpha-2,6-sialyl specific Sambucus nigra lectin (SNA). Taken together, the findings suggest that Neu1 desialylation of alpha-2,3-sialyl residues of TLR receptors enables in removing a steric hinderance to receptor association for TLR activation and cellular signaling.
Toll 样受体(TLR)的胞外域高度糖基化,在内凹表面有几个 N 连接糖基化位点。这些糖基 N 聚糖在 TLR 受体激活中的精确作用尚不清楚。最近,我们已经表明,神经氨酸酶 1(Neu1)而不是 Neu2、-3 和 -4,与幼稚和激活的巨噬细胞表面膜上的 TLR-2、-3 和 -4 受体形成复合物(Glycoconj J DOI 10.1007/s10719-009-9239-8)。Neu1 的激活是由 TLR 配体与各自受体结合诱导的。在这里,我们表明内毒素脂多糖(LPS)诱导的 MyD88/TLR4 复合物形成和随后的 NFkappaB 激活依赖于 Neu1 活性去除与 LPS 刺激的原代巨噬细胞、巨噬细胞和树突状细胞系中 TLR4 的β-半乳糖苷连接的α-2,3-唾液酸残基,但不依赖于原代 Neu1 缺陷型巨噬细胞。外源性α-2,3 唾液酸特异性神经氨酸酶(肺炎链球菌)和野生型 T. cruzi 转涎酸酶(TS),但不是催化失活突变 TSAsp98-Glu,介导 TLR4 二聚化,促进 MyD88/TLR4 复合物形成和 NFkappaB 激活,类似于 LPS 诱导的反应。在 TLR 缺陷型 HEK293 细胞中观察不到这些相同的 TLR 配体诱导的 NFkappaB 反应,但在稳定转染 TLR4/MD2 的 HEK293 细胞中重新建立,并且被α-2,3 唾液酸特异性山黧豆凝集素(MAL-2)、α-2,3 唾液酸特异性半乳糖凝集素-1 和神经氨酸酶抑制剂达菲显著抑制,但不受α-2,6 唾液酸特异性黑接骨木凝集素(SNA)的影响。总之,这些发现表明 Neu1 去唾液酸化 TLR 受体的α-2,3 唾液酸残基,可去除 TLR 激活和细胞信号转导中受体结合的空间位阻。